Metabolomics analysis of blood from patients (n = 42) undergoing surgery for suspected lung cancer was performed in this study. Venous and arterial blood was collected in both Streck and Heparin tubes. A total of 96 metabolites were detected, affected by sex (n = 56), collection tube (n = 33), and blood location (n = 8). These metabolites belonged to a wide array of compound classes including lipids, acids, pharmaceutical agents, signalling molecules, vitamins, among others. Phospholipids and carboxylic acids accounted for 28% of all detected compounds. Out of the 33 compounds significantly affected by collection tube, 18 compounds were higher in the Streck tubes, including allantoin and ketoleucine, and 15 were higher in the Heparin tubes,...
The metabolomics approach, defined as the study of all endogenously-produced low-molecular-weight co...
The project entitled “Study of serum metabolic profiles of patients with non-small cell lung cancer ...
Lung cancer is one of the most common causes of cancer death, for which no validated tumor biomarker...
Lung cancer is a leading cause of cancer deaths worldwide. Metabolic alterations in tumor cells coup...
Lung cancer is a leading cause of cancer deaths worldwide. Metabolic alterations in tumor cells coup...
Blood is a rich biological sample routinely collected in clinical and epidemiological studies. With ...
Epidemiological studies of associations between metabolites and cancer risk have typically focused o...
Background: Epidemiological studies of associations between metabolites and cancer risk have typical...
To access publisher's full text version of this article click on the hyperlink belowPlasma and serum...
Metabolomics has become a rising field of research for various diseases, particularly cancer. Increa...
This study explores for the first time the combination of serum, urine and bronchoalveolar lavage fl...
Identification of the NSCLC subtype at an early stage is still quite sophisticated. Metabolomics ana...
In this work, the variations in the metabolic profile of blood plasma from lung cancer patients and ...
Introduction. Blood biomarkers may support early diagnosis of lung cancer by enabling pre-selection ...
BackgroundUntargeted metabolomics was used in case-control studies of adenocarcinoma (ADC) lung canc...
The metabolomics approach, defined as the study of all endogenously-produced low-molecular-weight co...
The project entitled “Study of serum metabolic profiles of patients with non-small cell lung cancer ...
Lung cancer is one of the most common causes of cancer death, for which no validated tumor biomarker...
Lung cancer is a leading cause of cancer deaths worldwide. Metabolic alterations in tumor cells coup...
Lung cancer is a leading cause of cancer deaths worldwide. Metabolic alterations in tumor cells coup...
Blood is a rich biological sample routinely collected in clinical and epidemiological studies. With ...
Epidemiological studies of associations between metabolites and cancer risk have typically focused o...
Background: Epidemiological studies of associations between metabolites and cancer risk have typical...
To access publisher's full text version of this article click on the hyperlink belowPlasma and serum...
Metabolomics has become a rising field of research for various diseases, particularly cancer. Increa...
This study explores for the first time the combination of serum, urine and bronchoalveolar lavage fl...
Identification of the NSCLC subtype at an early stage is still quite sophisticated. Metabolomics ana...
In this work, the variations in the metabolic profile of blood plasma from lung cancer patients and ...
Introduction. Blood biomarkers may support early diagnosis of lung cancer by enabling pre-selection ...
BackgroundUntargeted metabolomics was used in case-control studies of adenocarcinoma (ADC) lung canc...
The metabolomics approach, defined as the study of all endogenously-produced low-molecular-weight co...
The project entitled “Study of serum metabolic profiles of patients with non-small cell lung cancer ...
Lung cancer is one of the most common causes of cancer death, for which no validated tumor biomarker...